Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.220
+0.050 (4.27%)
At close: Apr 2, 2025, 4:00 PM
1.244
+0.024 (1.93%)
After-hours: Apr 2, 2025, 7:50 PM EDT

Iterum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-24.77-38.37-44.43-91.56-52.01
Upgrade
Depreciation & Amortization
0.281.751.82.10.16
Upgrade
Other Amortization
2.292.342.344.110.93
Upgrade
Loss (Gain) From Sale of Investments
-0.35-1.15-0.180.64-
Upgrade
Stock-Based Compensation
0.360.7822.114.322.76
Upgrade
Other Operating Activities
8.15-7.45-2.4165.018.19
Upgrade
Change in Accounts Payable
-4.752.221.90.06-14.67
Upgrade
Change in Income Taxes
0.160.27-0.510.27-0.12
Upgrade
Change in Other Net Operating Assets
-8.140.270.93-0.77-9.77
Upgrade
Operating Cash Flow
-26.77-39.33-18.47-15.84-54.53
Upgrade
Capital Expenditures
-0-0.01-0.06-0.06-0.01
Upgrade
Investment in Securities
18.2123.3514.02-54.53-
Upgrade
Investing Cash Flow
18.2123.3413.96-54.6-0.01
Upgrade
Long-Term Debt Issued
----0.74
Upgrade
Long-Term Debt Repaid
---2.25-6.52-6.23
Upgrade
Net Debt Issued (Repaid)
---2.25-6.52-5.49
Upgrade
Issuance of Common Stock
26.691.030.4389.6458.37
Upgrade
Other Financing Activities
----11.59
Upgrade
Financing Cash Flow
26.691.03-1.8283.1364.48
Upgrade
Foreign Exchange Rate Adjustments
-0.08-0.06-0.050-0.01
Upgrade
Net Cash Flow
18.05-15.02-6.3812.699.93
Upgrade
Free Cash Flow
-26.77-39.34-18.54-15.9-54.54
Upgrade
Free Cash Flow Per Share
-1.36-3.04-1.51-1.46-34.07
Upgrade
Cash Interest Paid
--0.020.421
Upgrade
Cash Income Tax Paid
0.220.40.820.440.12
Upgrade
Levered Free Cash Flow
-19.4-21.31-13.5-28.78-8.72
Upgrade
Unlevered Free Cash Flow
-20.11-22.75-14.37-30.04-11.96
Upgrade
Change in Net Working Capital
9.07-4.41.8721.07-5.21
Upgrade
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q